Methadone treatment in Spain, 1994

Drug and Alcohol Dependence

Volumn 56, Issue 1, 1999, Pages 61-66

  Domingo Salvany, Antònia ^a   Pérez, Katerine ^a   Torrens, Marta ^b   Bravo, María José ^c   Antó, Josep M ^a   Alonso, Jordi ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c Delegacion Gobierno Plan Nac Drogas   (Spain)

Author keywords

Health services; HIV; Methadone

Indexed keywords

METHADONE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; DRUG DEPENDENCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; SPAIN;

ADOLESCENT; ADULT; FEMALE; HEALTH CARE SURVEYS; HIV INFECTIONS; HUMANS; MALE; METHADONE; MIDDLE AGED; NARCOTICS; QUESTIONNAIRES; SELF DISCLOSURE; SPAIN; SUBSTANCE ABUSE TREATMENT CENTERS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0344224244     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(99)00011-3     Document Type: Article

References (26)

1. Ball, J.C., Ross, J., 1991. The Effectiveness of Methadone Maintenance Treatment. Patients, Programs, Services and Outcome. Springer-Verlag, Ann Arbor, MI.
2. Bell, J., Caplehorn, J.R.M., Mcneil, D.R., 1994. The effect of intake procedures on performance in methadone maintenance. Addiction 89, 463-471.
3. Bertschy, G., 1995. Methadone maintenance treatment: an update. Eur. Arch. Psychiatry Clin. Neurosci. 245, 114-124.
4. Caplehorn, J.R.M., Bell, J., 1991. Methadone dosage and retention of patients in maintenance treatment. Med. J. Aust. 154, 195-199.
5. Caplehorn, J.R., Bell, J., Kleinbaum, D.G., Gebski, V.J., 1993a. Methadone dose and heroin use during maintenance treatment. Addiction 88, 119-124.
6. Caplehorn, J.R.M., Mcneil, D.R., Kleinbaum, D.G., 1993b. Clinic policy and retention in methadone maintenance. Int. J. Addict. 28, 73-89.
7. Condelli, W.S., 1993. Strategies for increasing retention in methadone programs. J. Psychoactive Drugs 25, 143-147.
8. D'Aunno, T., Vaughn, T.E., 1992. Variations in methadone treatment practices. J. Am. Med. Assoc. 267, 253-258.
9. De La Fuente, L., Barrio, G., Vicente, J., Bravo, M.J., Santacreu, J., 1995. The impact of drug-related deaths on mortality among young adults in Madrid. Am. J. Public Health 85, 102-105.
10. Domingo-Salvany, A., Hartnoll, R.L., Maguire, A., Brugal, M.T., Albertín, P., Caylà, J.A., Casabona, J., Suelves, J.M., 1998. Analytical considerations in the use of capture-recapture to estimate prevalence: case studies of the estimation of opiate use in the metropolitan area of Barcelona, Spain. Am. J. Epidemiol. 148, 732-740.
11. European Centre for the Epidemiological Monitoring of AIDS, 1997. Anonymous HIV/AIDS Surveillance in Europe 1994-1996. Saint Maurice, France, pp. 7-9.
12. Farrell, M., Ward, J., Mattick, R.H., Hall, W., Stimson, G.V., Des Jarlais, D., Gossop, M., Strang, J., 1994. Methadone maintenance treatment in opiate dependence: a review. Br. Med. J. 309, 997-1001.
13. Farrell, M., Neeleman, J.N., Gossop, M. et al., 1996. Spain. In: European Commission (Eds.), A Review of the Legislation, Regulation and Delivery of Methadone in 12 Member States of the European Union. Office for Official Publications of the European Communities, Luxembourg, pp. 123-135.
14. Gossop, M., Grant, M., 1991. A six country survey of the content and structure of heroin treatment programmes using methadone. Br. J. Addict. 86, 1151-1160.
15. Klee, H., Faugier, J., Hayes, C., Morris, J., 1991. The sharing of injecting equipment among drug users attending prescribing clinics and those using needle-exchanges. Br. J. Addict. 86, 217-223.
16. Marsch, L.A., 1998. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction 93, 515-532.
17. McGlothlin, W.H., Anglin, M.D., 1981. Long-term follow-up of clients of high- and low-dose methadone programs. Arch. Gen. Psychiatry 38, 1055-1063.
18. Mclellan, A.T., Arndt, I.O., Metzger, D.S., Woody, G.E., O'Brien, C.P., 1993. The effects of psychosocial services in substance abuse treatment. J. Am. Med. Assoc. 269, 1953-1959.
19. Novick, D.M., Joseph, H., Croxson, S., Salsitz, E.A., Wang, G., Richman, B.L., Poretsky, L., Keefe, J.B., Whimbey, E., 1990. Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients. Arch. Intern. Med. 150, 97-99.
20. Paredes, D., Del Llano, J., Ruiz, M., et al., 1994. Estimación de la Prevalencia de la Adicción a la Heroína en la Comunidad de Madrid Durante 1992. Comunidad de Madrid, Madrid.
21. Parrino, M.W., 1992. Executive Summary. In: Parrino, M.W. (Ed.), State Methadone Treatment Guidelines. US Department of Health and Human Services, Rockville.
22. Reisinger, M., 1993. Treatment of drug addiction and the epidemiology of AIDS. In: Reisinger, M (Ed.), AIDS and Drug Addiction in the European Community. Treatment and Mistreatment. EMCDDA, Brussels, pp. 15-36.
23. Saxon, A.J., Wells, E.A., Fleming, C., Jackson, T.R., Calsyn, D.A., 1996. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome. Addiction 91, 1197-1209.
24. Schoenbaum, E.E., Hartel, D., Selwyn, P.A., Klein, R.S., Davenny, K., Rogers, M., Feiner, C., Friedland, G., 1989. Risk factors for human immunodeficiency virus infection in intravenous drug users. New Engl. J. Med 321, 874-879.
25. Stein, Z., Susser, M., 1997. AIDS - an update on the global dynamics. Am. J. Public Health 87, 901-904.
26. Strain, E.C., Stitzer, M.L., Liebson, I.A., Bigelow, G.E., 1993. Methadone dose and treatment outcome. Drug Alcohol Depend. 33, 105-117.